chr19-11166602-T-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001136191.3(KANK2):āc.2512A>Gā(p.Met838Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00251 in 1,614,094 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001136191.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KANK2 | NM_001136191.3 | c.2512A>G | p.Met838Val | missense_variant | 13/13 | ENST00000586659.6 | NP_001129663.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KANK2 | ENST00000586659.6 | c.2512A>G | p.Met838Val | missense_variant | 13/13 | 1 | NM_001136191.3 | ENSP00000465650 | P1 | |
KANK2 | ENST00000589359.5 | c.2536A>G | p.Met846Val | missense_variant | 13/13 | 5 | ENSP00000468002 | |||
KANK2 | ENST00000588787.5 | c.622A>G | p.Met208Val | missense_variant | 5/5 | 5 | ENSP00000464896 | |||
KANK2 | ENST00000587317.1 | n.379A>G | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00190 AC: 289AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00180 AC: 449AN: 249312Hom.: 0 AF XY: 0.00182 AC XY: 245AN XY: 134942
GnomAD4 exome AF: 0.00257 AC: 3758AN: 1461786Hom.: 5 Cov.: 32 AF XY: 0.00244 AC XY: 1776AN XY: 727192
GnomAD4 genome AF: 0.00190 AC: 289AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.00185 AC XY: 138AN XY: 74478
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 07, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
KANK2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 14, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at